The study in question (Women's Health Study) reaffirmed this association, in this case specifically for postmenopausal females. Certainly other populations are likely to be affected as well.
Physicians are faced with a basic question when making a prescription of any drug to a patient: “What are the risks and benefits of this recommendation?” When it comes to statin drugs, the benefits have been grossly overstated, while the risks have continually been swept under the rug. That discussion is much longer than the space available in this commentary. Suffice it to say that it is important to point out that while statins reduce the heart attack risk in women, they do not appear to affect overall risk of death, possibly because an increased risk for diabetes cancels out the reduced heart attack risk. So, let me focus on the study at hand and try to make sense of such a high risk for diabetes in postmenopausal women using statins.
Fosamax works great for building bone density in the short term, but is it good for the long term? Excess bone deposition + no bone resorption --> heavy bones that spontaneously fracture in strange places.
Science suggests patients on fosamax should take a break from the meds at 5 years. Jacob Schor says in his practice he's suggesting a break after 3 years, to be conservative. Bisphosphonates formerly used to soften water in orange grove irrigation systems. ( the latest from Denver NaturopathicCollapse )
I felt some loneliness the first week I was here. But now, no. I have enough acquaintances to not feel lonely. The landlady, Marie, speaks English and her bf is American. And her niece, Emma, also…
Comments